A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors (Q46139159)
Jump to navigation
Jump to search
scientific article published on 21 November 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors |
scientific article published on 21 November 2016 |
Statements
A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors (English)
1 reference
Desamparados Roda
Teresa Macarulla
Rafael Morales-Barrera
Juan Manuel Sanchis-GarcĂa
Luna Musib
Nageshwar Budha
Jin Zhu
Michelle Nannini
Wai Y Chan
Raymond D Meng
Kui Lin
Yibing Yan
Premal Patel
José Baselga
21 November 2016
1 reference